• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发加巴喷丁可膨胀胃滞留控释给药系统。

Development of Gabapentin Expandable Gastroretentive Controlled Drug Delivery System.

机构信息

Faculty of Pharmacy, Nursing and Health Professions, Birzeit University, Al-Sahel Street 627, Ramallah, Palestine.

Samih Darwazah Institute for Pharmaceutical Industries, Faculty of Pharmacy, Nursing and Health Professions, Birzeit University, Al-Sahel Street 627, Ramallah, Palestine.

出版信息

Sci Rep. 2019 Aug 12;9(1):11675. doi: 10.1038/s41598-019-48260-8.

DOI:10.1038/s41598-019-48260-8
PMID:31406203
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6690886/
Abstract

Expandable drug delivery systems are one of many gastroretentive delivery systems which have emerged during the last few years. Expandable systems are usually folded in a capsule and expand to dimensions greater than the pyloric sphincter upon contact with gastric fluid. This prevents them from being evacuated by gastric emptying. The main objective of developing such systems is to increase the residence time of a specific drug in stomach; controlling its release, increasing its bioavailability and decreasing its side effects and dosing frequency. An expandable gastroretentive drug delivery system containing Gabapentin was developed using experimental design (D-optimal reduced quadratic design). This system was able to unfold at stomach pH in less than 15 minutes and obtain a controlled release of 78.1 ± 4.7% in 6 hours following zero-order release kinetic model. It is rigid in stomach and its rigidity decreases at intestinal pH. FTIR analysis indicated the occurrence of hydrogen bonding in Gabapentin when present in the developed system, which might be responsible for the drug's controlled release. XRD analysis indicated that Gabapentin physical properties changed from crystalline in the typical state to amorphous in the developed system.

摘要

可膨胀药物输送系统是近年来出现的众多胃滞留输送系统之一。可膨胀系统通常在胶囊中折叠,在与胃液接触时会膨胀到超过幽门括约肌的尺寸,从而防止它们被胃排空。开发此类系统的主要目的是延长特定药物在胃中的停留时间;控制其释放,增加其生物利用度,降低其副作用和用药频率。使用实验设计(D-最优减少二次设计)开发了一种含有加巴喷丁的可膨胀胃滞留药物输送系统。该系统能够在不到 15 分钟的时间内在胃 pH 值下展开,并在遵循零级释放动力学模型的情况下在 6 小时内获得 78.1±4.7%的控制释放。它在胃中是刚性的,在肠道 pH 值下其刚性会降低。傅里叶变换红外光谱(FTIR)分析表明,当加巴喷丁存在于所开发的系统中时,会发生氢键相互作用,这可能是药物控制释放的原因。X 射线衍射(XRD)分析表明,加巴喷丁的物理性质从典型状态的结晶态变为所开发系统中的无定形态。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7550/6690886/86a5062ae6a8/41598_2019_48260_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7550/6690886/08d756aa67c8/41598_2019_48260_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7550/6690886/0b7a12284c63/41598_2019_48260_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7550/6690886/55bcf9e8210a/41598_2019_48260_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7550/6690886/89c8b6064418/41598_2019_48260_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7550/6690886/62dcda42bb93/41598_2019_48260_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7550/6690886/b24d03bb4e4e/41598_2019_48260_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7550/6690886/f605c9c19187/41598_2019_48260_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7550/6690886/052fd14c3a7a/41598_2019_48260_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7550/6690886/ccd5acd2025f/41598_2019_48260_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7550/6690886/d9aa3ec0cab4/41598_2019_48260_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7550/6690886/8d498eef936a/41598_2019_48260_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7550/6690886/8c6b628e07f3/41598_2019_48260_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7550/6690886/d11728410699/41598_2019_48260_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7550/6690886/86a5062ae6a8/41598_2019_48260_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7550/6690886/08d756aa67c8/41598_2019_48260_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7550/6690886/0b7a12284c63/41598_2019_48260_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7550/6690886/55bcf9e8210a/41598_2019_48260_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7550/6690886/89c8b6064418/41598_2019_48260_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7550/6690886/62dcda42bb93/41598_2019_48260_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7550/6690886/b24d03bb4e4e/41598_2019_48260_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7550/6690886/f605c9c19187/41598_2019_48260_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7550/6690886/052fd14c3a7a/41598_2019_48260_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7550/6690886/ccd5acd2025f/41598_2019_48260_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7550/6690886/d9aa3ec0cab4/41598_2019_48260_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7550/6690886/8d498eef936a/41598_2019_48260_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7550/6690886/8c6b628e07f3/41598_2019_48260_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7550/6690886/d11728410699/41598_2019_48260_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7550/6690886/86a5062ae6a8/41598_2019_48260_Fig14_HTML.jpg

相似文献

1
Development of Gabapentin Expandable Gastroretentive Controlled Drug Delivery System.开发加巴喷丁可膨胀胃滞留控释给药系统。
Sci Rep. 2019 Aug 12;9(1):11675. doi: 10.1038/s41598-019-48260-8.
2
Preparation and evaluation of glyceryl monooleate-coated hollow-bioadhesive microspheres for gastroretentive drug delivery.制备和评价用于胃滞留型药物传递的甘油脂单油酸酯包衣的中空生物黏附微球。
Int J Pharm. 2011 Jul 15;413(1-2):103-9. doi: 10.1016/j.ijpharm.2011.04.030. Epub 2011 Apr 21.
3
Gastroretentive raft liquid delivery system as a new approach to release extension for carrier-mediated drug.胃滞留筏型液体给送系统——一种新的载体介导药物释放延长方法
Drug Deliv. 2018 Nov;25(1):1161-1174. doi: 10.1080/10717544.2018.1474969.
4
Formulation and evaluation of gastroretentive floating drug delivery system of dipyridamole.双嘧达莫胃滞留漂浮药物递送系统的制剂与评价
Drug Dev Ind Pharm. 2015 Apr;41(4):674-80. doi: 10.3109/03639045.2014.893355. Epub 2014 Mar 4.
5
Development and evaluation of a gastroretentive drug delivery system for the low-absorption-window drug celecoxib.用于低吸收窗药物塞来昔布的胃滞留型药物递送系统的研发与评价
PDA J Pharm Sci Technol. 2007 Mar-Apr;61(2):88-96.
6
Formulation and evaluation of novel controlled release of topical pluronic lecithin organogel of mefenamic acid.甲芬那酸新型局部用普朗尼克卵磷脂有机凝胶控释制剂的制备与评价
Drug Deliv. 2016 Nov;23(9):3573-3581. doi: 10.1080/10717544.2016.1212439. Epub 2016 Aug 5.
7
Chitosan-based gastroretentive floating drug delivery technology: an updated review.壳聚糖基胃滞留型漂浮药物传递技术:最新综述。
Expert Opin Drug Deliv. 2012 May;9(5):525-39. doi: 10.1517/17425247.2012.673581. Epub 2012 Mar 24.
8
Design and characterization of a novel 3D printed pressure-controlled drug delivery system.设计并描述一种新型的 3D 打印压力控制药物输送系统。
Eur J Pharm Sci. 2019 Dec 1;140:105060. doi: 10.1016/j.ejps.2019.105060. Epub 2019 Sep 6.
9
Highlighting the impact of chitosan on the development of gastroretentive drug delivery systems.强调壳聚糖对胃滞留型药物传递系统发展的影响。
Int J Biol Macromol. 2020 Sep 15;159:804-822. doi: 10.1016/j.ijbiomac.2020.05.104. Epub 2020 May 18.
10
Low molecular mass chitosan as carrier for a hydrodynamically balanced system for sustained delivery of ciprofloxacin hydrochloride.低相对分子质量壳聚糖作为载体的流体力学平衡系统用于盐酸环丙沙星的持续释放。
Acta Pharm. 2012 Jun;62(2):237-50. doi: 10.2478/v10007-012-0013-2.

引用本文的文献

1
A Comprehensive Review of Challenges in Oral Drug Delivery Systems and Recent Advancements in Innovative Design Strategies.口服给药系统中的挑战及创新设计策略的最新进展综述
Curr Pharm Des. 2025;31(5):360-376. doi: 10.2174/0113816128338560240923073357.
2
Quality by design approach for development and characterization of gabapentin-loaded solid lipid nanoparticles for intranasal delivery: , and histopathological evaluation.用于鼻内给药的加巴喷丁固体脂质纳米粒的设计质量开发与表征方法及组织病理学评价
Iran J Basic Med Sci. 2024;27(7):904-913. doi: 10.22038/IJBMS.2024.76281.16511.
3
In Vivo Evaluation of Thiamine Hydrochloride with Gastro-Retentive Drug Delivery in Healthy Human Volunteers Using Gamma Scintigraphy.

本文引用的文献

1
Overview on gastroretentive drug delivery systems for improving drug bioavailability.概述改善药物生物利用度的胃滞留型药物传递系统。
Int J Pharm. 2016 Aug 20;510(1):144-58. doi: 10.1016/j.ijpharm.2016.05.016. Epub 2016 May 9.
2
A novel gastroretentive porous microparticle for anti-Helicobacter pylori therapy: preparation, in vitro and in vivo evaluation.一种用于抗幽门螺杆菌治疗的新型胃滞留多孔微粒:制备、体外和体内评价
Int J Pharm. 2014 Mar 10;463(1):10-21. doi: 10.1016/j.ijpharm.2013.12.052. Epub 2014 Jan 6.
3
Pharmacokinetics, efficacy, and tolerability of a once-daily gastroretentive dosage form of gabapentin for the treatment of postherpetic neuralgia.
使用γ闪烁扫描术对健康人体志愿者中采用胃滞留给药系统的盐酸硫胺进行体内评估。
Pharmaceutics. 2023 Feb 17;15(2):691. doi: 10.3390/pharmaceutics15020691.
4
Advances in Oral Drug Delivery Systems: Challenges and Opportunities.口服给药系统的进展:挑战与机遇
Pharmaceutics. 2023 Feb 1;15(2):484. doi: 10.3390/pharmaceutics15020484.
5
Development of Novel Unfolding Film System of Itopride Hydrochloride Using Box-Behnken Design-A Gastro Retentive Approach.采用Box-Behnken设计法开发新型盐酸伊托必利展开膜系统——一种胃滞留给药方法
Pharmaceuticals (Basel). 2022 Aug 10;15(8):981. doi: 10.3390/ph15080981.
6
Gastroretentive Sustained-Release Tablets Combined with a Solid Self-Micro-Emulsifying Drug Delivery System Adsorbed onto Fujicalin®.胃滞留型缓释片与固体自微乳药物传递系统联合吸附于 Fujicalin®。
AAPS PharmSciTech. 2022 Jun 8;23(5):157. doi: 10.1208/s12249-022-02311-y.
7
Detailed Kinetic and Mechanistic Study for the Preparation of Silver Nanoparticles by a Chemical Reduction Method in the Presence of a Neuroleptic Agent (Gabapentin) at an Alkaline pH and its Characterization.在碱性pH条件下,于抗精神病药物(加巴喷丁)存在的情况下,通过化学还原法制备银纳米颗粒的详细动力学和机理研究及其表征。
ACS Omega. 2022 Feb 8;7(7):5739-5750. doi: 10.1021/acsomega.1c05499. eCollection 2022 Feb 22.
8
Gastroretentive Technologies in Tandem with Controlled-Release Strategies: A Potent Answer to Oral Drug Bioavailability and Patient Compliance Implications.胃滞留技术与控释策略相结合:解决口服药物生物利用度和患者依从性问题的有效方案。
Pharmaceutics. 2021 Sep 30;13(10):1591. doi: 10.3390/pharmaceutics13101591.
每日一次胃滞留型剂型加巴喷丁治疗带状疱疹后神经痛的药代动力学、疗效和耐受性。
J Pharm Sci. 2013 Apr;102(4):1155-64. doi: 10.1002/jps.23467. Epub 2013 Feb 4.
4
Osmotically regulated floating asymmetric membrane capsule for controlled site-specific delivery of ranitidine hydrochloride: optimization by central composite design.渗透压调节型漂浮不对称膜胶囊用于盐酸雷尼替丁的控制型定位释放:通过中心复合设计进行优化。
AAPS PharmSciTech. 2012 Dec;13(4):1492-501. doi: 10.1208/s12249-012-9870-8. Epub 2012 Oct 27.
5
Progressive steps of polymorphic transformation of gabapentin polymorphs studied by hot-stage FTIR microspectroscopy.热台傅里叶变换红外显微光谱法研究加巴喷丁多晶型物的多形性转变的渐进步骤。
J Pharm Pharm Sci. 2010;13(1):67-77. doi: 10.18433/j3fs32.
6
Gastroretentive drug delivery systems: current developments in novel system design and evaluation.胃滞留型药物传递系统:新型系统设计与评估的最新进展。
Curr Drug Deliv. 2009 Oct;6(5):451-60. doi: 10.2174/156720109789941687.
7
An innovative floating gastro retentive dosage system: formulation and in vitro evaluation.一种创新的漂浮型胃滞留给药系统:制剂与体外评价
Int J Pharm. 2009 Aug 13;378(1-2):23-9. doi: 10.1016/j.ijpharm.2009.05.027. Epub 2009 May 22.
8
Polymorphs of gabapentin.加巴喷丁的多晶型物。
Acta Crystallogr C. 2008 Mar;64(Pt 3):o105-8. doi: 10.1107/S0108270107066279. Epub 2008 Feb 9.
9
Gastroretentive Accordion Pill: Enhancement of riboflavin bioavailability in humans.胃滞留手风琴式胶囊:提高人体中核黄素的生物利用度。
J Control Release. 2006 Jul 20;113(3):208-15. doi: 10.1016/j.jconrel.2006.03.022. Epub 2006 Apr 26.
10
Gastroretentive delivery systems: a mini review.胃滞留给药系统:一篇综述短文
Drug Dev Ind Pharm. 2004;30(10):1019-28. doi: 10.1081/ddc-200040239.